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General: Reactions were carried out under nitrogen in flame-dried glassware. 
Tris(dibenzylideneacetone)dipalladium and (S)-Siphos-PE were purchased from Strem 
Chemical Co. and used without further purification.  All other reagents including all aryl 
and alkenyl bromides were purchased from commercial sources and used as received 
unless otherwise noted. Xylenes were purified by distillation over CaH2 prior to use in 
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reactions.  Methylene chloride and toluene were purified using a GlassContour solvent 
system. All yields refer to isolated compounds that are estimated to be >95% pure as 
judged by 1H NMR analysis. !The yields reported in the supporting information describe 
the result of a single experiment, whereas yields reported in Tables 1–2 and equations 
2–4 are average yields of two or more experiments. Thus, the yields reported in the 
supporting information may differ from those shown in Table 2 and equations 2–4. !
 
General procedure for the synthesis of N-allylurea substrates.  A flame-dried round 
bottom flask equipped with a stirbar was cooled under a stream of nitrogen. The flask 
was charged with the appropriate isocyanate (1.0 equiv) and methylene chloride (0.60 
M). The resulting solution was cooled to 0 °C and stirred for 5 min, then the allylic amine 
(1.1 equiv) was added dropwise. The solution was warmed to rt and stirred for five h. 
The mixture was then concentrated in vacuo and purified by flash chromatography on 
silica gel. 
!
1-Allyl-3-{4-[benzyl(methyl)amino]phenyl}-1-methylurea (1a):  A flame dried Schlenk 
flask equipped with a stirbar was cooled under a stream of nitrogen and charged with 1-
allyl-3-(4-bromophenyl)-1-methylurea (1.00 g, 3.72 mmol), lithium 
bis(trimethylsilyl)amide (1.37 g, 4.46 mmol), Pd2(dba)3 (34.1 mg, 0.0372 mmol), and 
DavePhos (35.1 mg, 0.0893 mmol). The flask was purged with N2 pressure for 30 s 
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resulting mixture was heated to 65 °C with stirring for 15 h, then was cooled to rt. A 
solution of 1M HCl (8 mL) was added and the resulting mixture was stirred at rt for five 
min. A solution of saturated aqueous NaHCO3 (8 mL) was slowly added and the mixture 
was transferred to a separatory funnel after bubbling ceased. The mixture was extracted 
with ethyl acetate (3 x 20 mL) then the combined organic layers were dried over 
anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude product was purified 
by flash chromatography on silica gel to afford 450 mg (40%) of the title compound as a 
light brown solid, mp 93–97 °C. 1H NMR (400 MHz, CDCl3) ! 7.31–7.14 (m, 7H), 6.68 
(d, J = 9.0 Hz, 2H), 6.18 (s, br, 1H), 5.83 (ddt, J = 5.5, 5.2, 12.0 Hz, 1H), 5.26–5.19 (m, 
2H), 4.46 (s, 2H), 3.93 (d, J = 5.5 Hz, 2H), 2.96 (s, 3H), 2.94 (s, 3H); 13C NMR (100 
MHz, CDCl3) ! 156.2, 146.5, 138.9, 133.6, 128.8, 128.4, 126.8, 126.7, 122.5, 116.7, 
113.0, 57.0, 51.4, 38.7, 34.4; IR (film) 1637 cm-1. MS (CI) 310.1916 (310.1914 calcd for 




1-Allyl-3-(4-methoxyphenyl)-1-methylurea (1b): The reaction of N-allylmethylamine 
(0.47 mL, 4.92 mmol) with 4-methoxyphenyl isocyanate (0.58 mL, 4.47 mmol) according 
to the general procedure afforded 841 mg (85%) of the title compound as a white solid, 
mp 52–55 °C. 1H NMR (400 MHz, CDCl3) ! 7.24 (d, J = 9.0 Hz, 2H), 6.81 (d, J = 9.0 Hz, 
2H), 6.61 (s, br, 1H), 5.90–5.78 (m, 1H), 5.25 (d, J = 5.5 Hz, 1H), 5.22 (s, 1H), 3.94 (d, J 
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133.5, 132.2, 122.1, 116.8, 114.0, 55.5, 51.5, 34.5; IR (film) 1638 cm-1. MS (CI) 




1-Allyl-1-methyl-3-phenylurea (1c): The reaction of N-allylmethylamine (0.37 mL, 3.85 
mmol) with phenyl isocyanate (0.42 mL, 3.50 mmol) according to the general procedure 
afforded 644 mg (88%) of the title compound as a white solid, mp 71–74 °C. 1H NMR 
(400 MHz, CDCl3) ! 7.34 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 7.8 Hz, 2H), 6.98 (t, J = 7.4 
Hz, 1H), 6.48 (s, br, 1H), 5.88–5.78 (m, 1H), 5.26–5.19 (m, 2H), 3.93 (d, J = 5.5 Hz, 
2H), 2.96 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 155.6, 139.2, 133.4, 128.8, 122.9, 
119.8, 116.9, 51.5, 34.5; IR (film) 1639 cm-1. MS (CI) 191.1180 (191.1179 calcd for 




1-Allyl-3-(4-bromophenyl)-1-methylurea (1d): The reaction of N-allylmethylamine 
(0.80 mL, 8.44 mmol) with 4-bromophenyl isocyanate (1.51 g, 7.67 mmol) according to 
the general procedure afforded 1.88 g (91%) of the title compound as a white solid, mp 










!!!!!!!!!!!!!!!!!!! ! !!!!!!!!!!"! '!
2H), 6.47 (s, br, 1H), 5.81 (ddt, J = 5.5, 5.6, 9.9 Hz, 1H), 5.27–5.19 (m, 2H), 3.92 (d, J = 
5.3 Hz, 2H), 2.96 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 155.2, 138.3, 133.2, 131.7, 
121.4, 117.0, 115.2, 51.5, 34.6; IR (film) 1634 cm-1. MS (CI) 269.0282 (269.0284 calcd 
for C11H13BrN2O, M + H
+). 
!
1-Allyl-3-(4-cyanophenyl)-1-methylurea (1e): The reaction of N-allylmethylamine 
(0.73 mL, 7.65 mmol) with 4-cyanophenyl isocyanate (1.00 g, 6.96 mmol) according to 
the general procedure afforded 1.17 g (78%) of the title compound as a white solid, mp 
119–122 °C.  1H NMR (500 MHz, CDCl3) ! 7.54 (d, J = 8.8 Hz, 2H), 7.49 (d, J = 8.8 Hz, 
2H), 6.69 (s, br, 1H), 5.86 (ddt, J = 5.1, 5.4, 11.9 Hz, 1H), 5.32–5.25 (m, 2H), 3.80 (d, J 
= 5.4 Hz, 2H), 3.03 (s, 3H) ; 13C NMR (100 MHz, CDCl3) ! 154.6, 143.5, 133.1, 132.9, 
119.2, 119.0, 117.4, 105.3, 51.6, 34.8; IR (film) 1664 cm-1. MS (CI) 216.1135 (216.1131 




1-Allyl-1-methyl-3-(4-nitrophenyl)urea (1f): The reaction of N-allylmethylamine (0.77 
mL, 8.09 mmol) with 4-nitrophenyl isocyanate (1.21 g, 7.35 mmol) according to the 
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78–81 °C. 1H NMR (400 MHz, CDCl3) ! 8.10 (d, J = 9.2 Hz, 2H), 7.53 (d, J = 9.2 Hz, 
2H), 7.00 (s, br, 1H), 5.84 (ddt, J = 5.3, 5.6, 11.4 Hz, 1H), 5.32–5.22 (m, 2H), 3.98 (d, J 
= 5.3 Hz, 2H), 3.02 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 154.7, 145.6, 142.2, 132.8, 
125.0, 118.4, 117.4, 51.6, 34.8; IR (film) 1660 cm-1. MS (CI) 236.1037 (236.1030 calcd 




1-Methyl-1-(2-methylallyl)-3-(4-nitrophenyl)urea (3): A flame dried flask equipped 
with a stirbar was cooled under a stream of nitrogen and charged with 3-bromo-2-
methylpropene (4.60 mL, 45 mmol). The flask was cooled to 0 °C and stirred for five 
min, then methylamine (27.2 mL, 225 mmol, 33% solution in EtOH) was added and the 
resulting mixture was warmed to rt and stirred for 15 h. A solution of 1M NaOH (20 mL) 
was added and the resulting mixture was transferred to a separatory funnel. The 
mixture was extracted with ether (3 x 20 mL) then the combined organic layers were 
washed with 1M NaOH (1x12 mL), dried over anhydrous Na2SO4, filtered, and partially 
concentrated in vacuo (to remove excess methylamine) to afford N,2-dimethylprop-2-
en-1-ylamine as a solution in ethanol. The solution was transferred to a flask equipped 
with a stirbar and cooled to –10 °C. Neat 4-nitrophenyl isocyanate (1.64 g, 10 mmol) 
was added and the resulting solution and the reaction was slowly warmed to rt over the 
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product was purified by flash column chromatography to yield 350 mg (14 %) of the title 
compound as a yellow solid, mp 79–82 °C. 1H NMR (500 MHz, CDCl3) ! 8.13 (d, J = 9.3 
Hz, 2H), 7.52 (d, J = 9.1 Hz, 2H), 6.92 (s, br, 1H), 5.03 (s, 1H) 4.96 (s, 1H), 3.90 (s, 2H), 
3.05 (s, 3H), 1.78 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 154.7, 145.5, 142.3, 141.0, 
125.0, 118.3, 112.5, 55.2, 35.3, 19.7; IR (film) 1658 cm-1. MS (CI) 250.1191 (250.1186 
calcd for C12H15N3O3, M + H
+). 
!
1-Cinnamyl-1-methyl-3-(4-nitrophenyl)urea (5): A flame dried flask equipped with a 
stirbar was cooled under a stream of nitrogen and charged with cinnamyl bromide (4.33 
g, 22 mmol). The flask was cooled to 0 °C and stirred for five min, then methylamine 
(27.2 mL, 225 mmol, 33% solution in EtOH) was added and the resulting mixture was 
warmed to rt and stirred for 15 h. A solution of 1M NaOH (20 mL) was added and the 
resulting mixture was transferred to a separatory funnel. The mixture was extracted with 
ether (3 x 20 mL) then the combined organic layers were washed with 1M NaOH (1x12 
mL), dried over anhydrous Na2SO4, filtered, and partially concentrated in vacuo (to 
remove excess methylamine) to afford (E)-N-methyl-3-phenylprop-2-en-1-ylamine as a 
solution in ethanol. The solution was transferred to a flask equipped with a stirbar and 
cooled to –10 °C. Neat 4-nitrophenyl isocyanate (1.44g, 8.8 mmol) was added and the 
resulting solution and the reaction was slowly warmed to rt over the course of five h. 
The reaction mixture was then concentrated in vacuo and the crude product was 
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a white solid, mp 120–124 °C. 1H NMR (500 MHz, CDCl3) ! 8.14 (d, J = 9.1 Hz, 2H), 
7.55 (d, J = 9.3 Hz, 2H), 7.40 (d, J = 7.3 Hz, 2H), 7.34 (t, J = 7.3 Hz, 2H), 7.28 (t, J = 7.1 
Hz, 1H), 6.92 (s, br, 1H), 6.60 (d, J = 16.0 Hz, 1H), 6.23 (dt, J = 5.9, 15.9 Hz, 1H), 4.17 
(d, J= 5.9 Hz, 2H), 3.10 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 154.5, 145.4, 142.4, 
135.9, 132.8, 128.7, 128.2, 126.5, 125.1, 123.9, 118.4, 51.2, 34.8; IR (film) 1659 cm-1. 
MS (CI) 312.1353 (312.1343 calcd for C17H17N3O3, M + H
+). 
 
General procedure for asymmetric Pd-catalyzed carboamination reactions of N-
allylurea derivatives. A flame-dried Schlenk tube equipped with a stirbar was cooled 
under a stream of nitrogen and then charged with Pd2(dba)3 (2 mol %), (S)-Siphos-PE 
(6 mol %), the urea substrate (1.0 equiv), and NaOtBu (2.0 equiv). The flask was purged 
with N2, then the aryl or alkenyl halide (2.0 equiv), the additive (H2O, 2.0 equiv; or TFA, 
40 mol % if needed) and xylenes (0.20 M, for reactions at 120 °C) or toluene (0.20 M, 
for reactions at 90 °C) were added. The resulting mixture was heated to 90 °C or 120 °C 
with stirring until the starting material had been consumed as judged by TLC analysis. 
The reaction mixture was then cooled to rt, saturated aqueous ammonium chloride 
(6mL/mmol substrate) was added, and the mixture was transferred to a separatory 
funnel. The mixture was extracted with ethyl acetate (3 x 5 mL) then the combined 
organic layers were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. 
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(–)-(4S)-3-{4-[Benzyl(methyl)amino]phenyl}-4-[4-(tert-butyl)benzyl]-1-
methylimidazolidin-2-one (2a). The general procedure was employed for the coupling 
of 1-allyl-3-{4-[benzyl(methyl)amino]phenyl}-1-methylurea (0.10 mmol, 30.9 mg) and 4-
bromo-tert-butylbenze (0.20 mmol, 42.6 mg), using a catalyst composed of Pd2(dba)3 
(0.002 mmol, 1.8 mg) and (S)-Siphos-PE (0.006 mmol, 3.0 mg), a reaction temperature 
of 90 °C, and a reaction time of 12 h. This procedure afforded the title compound (28.7 
mg, 65%) as an orange oil: ["]23D –23.2 (c 0.68, CH2Cl2). 
1H NMR (400 MHz, CDCl3) ! 
7.34–7.23 (m, 9H), 7.05 (d, J = 8.2 Hz, 2H), 6.77 (d, J = 9.0 Hz, 2H), 4.52 (s, 2H), 4.28–
4.20 (m, 1H), 3.30 (app. t, J = 8.6 Hz, 1H), 3.12 (dd, J = 6.1, 8.8 Hz, 1H), 3.06 (dd, J = 
3.3, 13.7 Hz, 1H), 3.00 (s, 3H), 2.79 (s, 3H) 2.58 (dd, J = 10.0, 13.5 Hz, 1H), 1.30 (s, 
9H); 13C NMR (125 MHz, CDCl3); 159.5, 149.6, 147.3, 139.0, 133.8, 128.8, 128.6, 
128.2, 126.9, 126.8, 125.5, 124.5, 112.9, 57.0, 55.9, 50.1, 38.7, 38.0, 34.4, 31.4, 31.3; 
IR (film) 1704 cm-1; MS (CI) 442.2866 (442.2859 calcd for C29H35N3O, M + H
+). The 
enantiopurity was determined to be 73% ee by chiral HPLC analysis (chiralcel ADH, 25 





(2b). The general procedure was employed for the coupling of 1-allyl-3-(4-
methoxyphenyl)-1-methylurea (0.10 mmol, 22.1 mg) and 4-bromo-tert-butylbenze (0.20 
mmol, 42.6 mg) using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-
Siphos-PE (0.006 mmol, 3.0 mg), a reaction temperature of 90 °C, and a reaction time 
of 12 h. This procedure afforded the title compound (33.0 mg, 93%) as an orange oil: 
["]23D –10.1 (c 0.76, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ! 7.38 (d, J = 9.0 Hz, 2H), 7.31 
(d, J = 8.3 Hz, 2H), 7.06 (d, J = 8.3 Hz, 2H), 6.93 (d, J = 9.0 Hz, 2H), 4.37–4.29 (m, 1H), 
3.82 (s, 3H), 3.36 (app. t, J = 8.7 Hz, 1H), 3.17 (dd, J = 5.9, 9.2 Hz, 1H), 3.05 (dd, J = 
3.7, 13.7 Hz, 1H), 2.81 (s, 3H), 2.62 (dd, J = 9.8, 13.7 Hz, 1H), 1.31 (s, 9H); 13C NMR 
(100 MHz, CDCl3) 159.0, 156.4, 149.6, 133.5, 131.8, 128.8, 125.5, 123.8, 114.3, 55.5, 
55.4, 49.8, 37.8, 34.4, 31.3, 31.2; IR (film) 1700 cm-1; MS (CI) 353.2232 (353.2224 
calcd for C22H28N2O2, M + H
+). The enantiopurity was determined to be 79% ee by chiral 
HPLC analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.50 mL/min, # 198 




(–)-(4S)-4-[4-(tert-Butyl)benzyl]-1-methyl-3-phenylimidazolidin-2-one (2c). The 
general procedure was employed for the coupling of 1-allyl-1-methyl-3-phenylurea (0.10 
mmol, 17.6 mg) and 4-bromo-tert-butylbenze (0.20 mmol, 42.6 mg) using a catalyst 
composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-Siphos-PE (0.006 mmol, 3.0 mg), 
a reaction temperature of 90 °C and a reaction time of 12 h. This procedure afforded the 
title compound (29.0 mg, 90%) as white solid, mp 67–70 °C: ["]23D –19.4 (c 0.55, 
CH2Cl2); 
1H NMR (400 MHz, CDCl3) ! 7.55 (d, J = 8.6 Hz, 2H), 7.37 (t, J = 7.4 Hz, 2H), 
7.32 (d, J = 8.4 Hz, 2H), 7.12–7.06 (m, 3H), 4.48–4.40 (m, 1H), 3.37 (app. t, J = 8.6 Hz, 
1H), 3.20 (dd, J = 4.9, 8.4 Hz, 1H), 3.11 (dd, J = 3.3, 13.8 Hz, 1H), 2.81 (s, 3H), 2.64 
(dd, J = 9.8, 13.8 Hz, 1H), 1.30 (s, 9H); 13C NMR (100 MHz, CDCl3) 158.3, 149.7, 138.9, 
133.5, 129.0, 128.8, 125.6, 123.4, 120.7, 54.4, 49.4, 37.5, 34.4, 31.3, 31.0; IR (film) 
1707 cm-1; MS (CI) 323.2125 (323.2118 calcd for C21H26N2O, M + H
+). The 
enantiopurity was determined to be 78% ee by chiral HPLC analysis (chiralcel ADH, 25 





(2d). The general procedure was employed for the coupling of 1-allyl-3-(4-
bromophenyl)-1-methylurea (0.10 mmol, 26.9 mg) and 4-bromo-tert-butylbenze (0.20 
mmol, 42.6 mg) using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-
Siphos-PE (0.006 mmol, 3.0 mg), a reaction temperature of 90 °C and a reaction time of 
12 h. This procedure afforded the title compound (18.0 mg, 45%) as an orange oil: ["]23D 
–41.6 (c 0.42, CH2Cl2); 
1H NMR (500 MHz, CDCl3) ! 7.49–7.43 (m, 4H), 7.32 (d, J = 8.3 
Hz, 2H), 7.07 (d, J = 8.1 Hz, 2H), 4.44–4.38 (m, 1H), 3.39 (app. t, J = 8.8 Hz, 1H), 3.22 
(dd, J = 4.6, 9.0 Hz, 1H), 3.07 (dd, J = 3.7, 13.8 Hz, 1H), 2.82 (s, 3H), 2.66 (dd, J = 9.5, 
13.8 Hz, 1H), 1.32 (s, 9H); 13C NMR (100 MHz, CDCl3) 157.9, 150.0, 138.1, 133.3, 
131.9, 128.8, 125.6, 121.9, 116.0, 54.2, 49.2, 37.4, 34.3, 31.3, 31.9; IR (film) 1708 cm-1; 
MS (CI) 401.1230 (401.1223 calcd for C21H25BrN2O, M + H
+). The enantiopurity was 
determined to be 83% ee by chiral HPLC analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% 





(2e): The general procedure was employed for the coupling of 1-allyl-3-(4-
cyanophenyl)-1-methylurea (0.10 mmol, 21.5 mg) and 4-bromo-tert-butylbenze (0.20 
mmol, 42.6 mg) using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-
Siphos-PE (0.006 mmol, 3.0 mg), a reaction temperature of 120 °C and a reaction time 
of 14 h. This procedure afforded the title compound (30.2 mg, 87%) as a light orange 
solid, mp 108–113 °C: ["]23D –73.6 (c 0.91, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ! 7.75 
(d, J = 9.0 Hz, 2H), 7.63 (d, J = 9.0 Hz, 2H), 7.35 (d, J = 8.3 Hz, 2H), 7.10 (d, J = 8.3 
Hz, 2H), 4.50 (m, 1H), 3.46 (app. t, J = 8.8 Hz, 1H), 3.28 (dd, J = 3.5, 9.2 Hz, 1H), 3.10 
(dd, J = 3.5, 14.1 Hz, 1H), 2.83 (s, 3H) 2.73 (dd, J = 9.2, 14.0 Hz, 1H), 1.32 (s, 9H); 13C 
NMR (100 MHz, CDCl3) ! 156.9, 150.2, 143.2, 133.1, 132.6, 128.8, 125.7, 119.2, 118.5, 
105.0, 53.6, 48.7, 37.3, 34.5, 31.3, 30.8; IR (film) 1712 cm-1; MS (CI) 348.2082 
(348.2070 calcd for C22H25N3O, M + H
+). The enantiopurity was determined to be 86% 
ee by chiral HPLC analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 








The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 4-bromo-tert-butylbenzene (0.40 mmol, 85.2 
mg) using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE 
(0.012 mmol 6.1 mg), a reaction temperature of 115 °C and a reaction time of 18 h. This 
procedure afforded the title compound (59.6 mg, 81%) and 91% ee as a bright yellow 
solid, mp 115–118 °C: ["]23D –102.3 (c 1.49, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ! 8.22 
(d, J = 9.2 Hz, 2H), 7.78 (d, J = 9.4 Hz, 2H), 7.34 (d, J = 8.2 Hz, 2H), 7.9 (d, J = 8.2 Hz, 
2H), 4.56–4.49 (m, 1H), 3.48 (app. t, J = 9.0 Hz, 1H), 3.29 (dd, J = 3.0, 9.3 Hz, 1H), 
3.11 (dd, J = 3.5, 13.8 Hz, 1H), 2.83 (s, 3H), 2.75 (dd, J = 9.0, 13.9 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) ! 156.7, 150.3, 145.2, 141.9, 132.5, 128.8, 125.8, 125.0, 117.7, 53.7, 
48.6, 37.3, 34.5, 31.3, 30.8; IR (film) 1717 cm-1. MS (CI) 368.1968 (368.1969 calcd for 
C21H25N3O3, M + H
+). The enantiopurity was determined to be 92% ee by chiral HPLC 
analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.50 mL/min, # 198 nm, 
RT= 6.1 and 9.4 min). 
(–)-(4S)-4-[4-(tert-Butyl)benzyl]-1-methyl-3-(4-nitrophenyl)imidazolidin-2-one (X). 
The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.10 mmol, 23.5 mg) and 4-iodo-tert-butylbenzene (0.20 mmol, 52.0 
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mg) using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-Siphos-PE 
(0.006 mmol, 3.0 mg), a reaction temperature of 115 °C and a reaction time of 18 h. 
This procedure afforded the title compound (19.0 mg, 60%) as a bright yellow solid. This 
material contained ca 35% of an inseparable unidentified regioisomer. The enantiopurity 
was determined to be 47% ee by chiral HPLC analysis. Spectroscopic data were 




(2g). The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 4-bromobenzotrifluoride (0.40 mmol, 90.0 
mg) using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE 
(0.012 mmol 6.1 mg), H2O (0.40 mmol, 7 $L) as an additive, a reaction temperature of 
115 °C and a reaction time of 18 h. This procedure afforded the title compound (54.6 
mg, 72%) as a bright yellow solid, mp 161–164 °C: ["]23D –75.1 (c 11.5, CH2Cl2); 
1H 
NMR (400 MHz, CDCl3) ! 8.23 (d, J = 9.2 Hz, 2H), 7.78 (d, J = 9.3 Hz, 2H), 7.58 (d, J = 
8.0 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 4.64–4.58 (m, 1H), 3.51 (app. t, J = 9.0 Hz, 1H), 
3.24 (dd, J = 3.1, 9.3 Hz, 1H), 3.17 (dd, J = 3.1, 9.3 Hz, 1H), 3.01 (dd, J = 8.6, 14.0 Hz, 
1H), 2.80 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 156.5, 144.8, 142.1, 139.6, 129.6 (q, 
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65.2 Hz), 129.5, 125.8 (q, 3.81), 125.1, 123.9 (q, 272.0 Hz), 117.8, 53.2, 48.3, 37.5, 
30.7; IR (film) 1708 cm-1. MS (CI) 380.1211 (380.1217 calcd for C18H16F3N3O3, M + H
+). 
The enantiopurity was determined to be 95% ee by chiral HPLC analysis (chiralcel 





(2h). The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 3-bromobenzotrifluoride (0.40 mmol, 90.0 
mg) using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE 
(0.012 mmol 6.1 mg), H2O (0.40 mmol, 7 $L) as an additive, a reaction temperature of 
115 °C and a reaction time of 18 h. This procedure afforded the title compound (53.1 
mg, 70%) as a bright yellow solid, mp 145–148 °C: ["]23D –64.1 (c 1.16, CH2Cl2); 
1H 
NMR (400 MHz, CDCl3) ! 8.22 (d, J = 9.0 Hz, 2H), 7.77 (d, J = 9.0 Hz, 2H), 7.53 (d, J = 
7.8 Hz, 1H), 7.44 (t, J = 7.6 Hz, 1H), 7.38 (s, 1H), 7.32 (d, J = 7.6 Hz, 1H), 4.65–4.58 
(m, 1H), 3.53 (app. t, J = 9.0 Hz, 1H), 3.24 (dd, J = 2.7, 9.2 Hz, 1H), 3.15 (dd, J = 3.5, 
14.1 Hz, 1H), 2.93 (dd, J = 8.4, 14.0 Hz, 1H), 2.79 (s, 3H); 13C NMR (125 MHz, CDCl3) 
! 156.5, 144.9, 142.1, 136.1, 132.7, 131.2 (q, J = 32.4 Hz), 129.4, 125.8 (q, J = 3.8 Hz), 
125.1, 124.2 (q, J = 3.8 Hz), 123.9 (q, J = 271.8 Hz), 117.8, 53.1, 48.4, 37.6, 30.7; IR 
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(film) 1714 cm-1. MS (CI) 380.1224 (380.1217 calcd for C18H16F3N3O3, M + H
+). The 
enantiopurity was determined to be 88% ee by chiral HPLC analysis (chiralcel ADH, 25 




(2i). The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 2-bromobenzotrifluoride (0.40 mmol, 90.0 
mg), using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE 
(0.012 mmol 6.1 mg), H2O (0.40 mmol, 7 $L) as an additive, a reaction temperature of 
115 °C and a reaction time of 18 h. This procedure afforded the title compound (42.5 
mg, 56%) as a bright yellow solid, mp 70–73 °C: ["]23D –98.7 (c 0.72, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) ! 8.14 (d, J = 9.0 Hz, 2H), 7.72–7.64 (m, 3H), 7.44 (t, J = 7.4 Hz, 1H), 
7.34 (t, J = 7.6 Hz, 1H), 7.26 (d, J = 8.6 Hz, 1H), 4.72–4.64 (m, 1H), 3.43 (app. t, J = 9.0 
Hz, 1H), 3.36 (dd, J = 5.1, 14.4 Hz, 1H), 3.20 (dd, J = 2.0, 9.3 Hz, 1H), 2.96 (dd, J = 9.0, 
14.3 Hz, 1H), 2.87 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 156.7, 145.1, 142.0, 134.4, 
132.1, 129.2 (q, J = 30.0 Hz), 127.5, 126.6 (q, J = 5.7 Hz), 124.8, 124.4 (q, J = 272.3 
Hz), 118.0, 53.1, 48.3, 35.0, 30.9 (one peak is missing due to incidental equivalence); 
IR (film) 1722 cm-1. MS (CI) 380.1226 (380.1217 calcd for C18H16F3N3O3, M + H
+). The 
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enantiopurity was determined to be 83% ee by chiral HPLC analysis (chiralcel ADH, 25 
cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 195 nm, RT= 7.9 and 12.5 min). 
 
!
(–)-(4S)-4-(4-Benzoylbenzyl)-1-methyl-3-(4-nitrophenyl)imidazolidin-2-one (2j). The 
general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 4-bromobenzophenone (0.40 mmol, 104.4 
mg) using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE 
(0.012 mmol 6.1 mg), H2O (0.40 mmol,  7 $L) as an additive, a reaction temperature of 
115 °C and a reaction time of 18 h. This procedure afforded the title compound (68.1 
mg, 82%) as a bright yellow solid, mp 115–118 °C: ["]23D –53.7 (c 0.97, CH2Cl2); 
1H 
NMR (400 MHz, CDCl3) ! 8.21 (d, J = 9.3 Hz, 2H), 7.80–7.72 (m, 6H), 7.57 (t, J = 7.4 
Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 7.26 (d, J = 8.2 Hz, 2H), 4.65–4.58 (m, 1H), 3.50 (app. 
t, J = 9.0 Hz, 1H), 3.26 (dd, J = 3.1, 9.2 Hz, 1H), 3.18 (dd, J = 3.5, 14.0 Hz, 1H), 2.91 
(dd, J = 8.8, 13.9 Hz, 1H), 2.80 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 196.1, 156.6, 
145.0, 142.1, 140.3, 137.3, 136.6, 132.6, 130.6, 130.0, 129.2, 128.4, 125.1, 117.8, 53.2, 
48.4, 37.8, 34.4, 30.8; IR (film) 1715, 1657 cm-1. MS (CI) 416.1620 (416.1605 calcd for 
C24H21N3O4, M + H
+). The enantiopurity was determined to be 86% ee by chiral HPLC 
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analysis (ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 195 nm, RT= 39.0 
and 54.9 min.) 
 
 
(–)-(4S)-4-(4-Fluorobenzyl)-1-methyl-3-(4-nitrophenyl)imidazolidin-2-one (2k). The 
general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 4-bromofluorobenzene (0.40 mmol, 70.0 
mg) using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE 
(0.012 mmol 6.1 mg), H2O (0.40 mmol,  7 $L) as an additive, a reaction temperature of 
115 °C and a reaction time of 18 h. This procedure afforded the title compound (43.0 
mg, 65%) as a bright yellow solid, mp 153–157 °C: ["]23D –75.4 (c 1.10, CH2Cl2); 
1H 
NMR (400 MHz, CDCl3) ! 8.22 (d, J = 9.3 Hz, 2H), 7.88 (d, J = 9.3 Hz, 2H), 7.14–7.08 
(m, 2H), 7.01 (app. t, J = 8.6 Hz, 2H), 4.58–4.51 (m, 1H), 3.49 (app. t, J = 9.0 Hz, 1H), 
3.24 (dd, J = 3.1, 9.2 Hz, 1H), 3.06 (dd, J = 3.3, 14.0 Hz, 1H), 2.86–2.75 (m, 1H), 2.77 
(s, 3H); 13C NMR (100 MHz, CDCl3) ! 162.1 (d, J = 245.0 Hz), 156.6 145.0, 142.0, 
131.1 (d, J= 3.5 Hz), 130.7 (d, J = 8.0 Hz), 125.1, 117.7, 115.8 (d, J = 21.3 Hz), 53.4, 
48.2, 36.8, 30.7; IR (film) 1717 cm-1. MS (CI) 330.1258 (330.1248 calcd for 
C17H16FN3O3, M + H
+). The enantiopurity was determined to be 94% ee by chiral HPLC 
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analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 198 nm, 
RT= 12.0 and 22.7 min). 
 
!
(–)-(4S)-4-(4-Chlorobenzyl)-1-methyl-3-(4-nitrophenyl)imidazolidin-2-one (2l). The 
general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 4-bromochlorobenzene (0.40 mmol, 76.6 
mg) using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE 
(0.012 mmol 6.1 mg), H2O (0.40 mmol, 7 $L) as an additive, a reaction temperature of 
115 °C and a reaction time of 18 h. This procedure afforded the title compound (51.2 
mg, 74%) as a bright yellow solid, mp 144–147 °C: ["]23D –72.9 (c 0.81, CH2Cl2); 
1H 
NMR (400 MHz, CDCl3) ! 8.24 (d, J = 9.3 Hz, 2H), 7.78 (d, J = 9.3 Hz, 2H), 7.30 (d, J = 
8.3 Hz, 2H), 7.08 (d, J = 8.2 Hz, 2H), 4.57–4.50 (m, 1H), 3.48 (app. t, J = 9.0 Hz, 1H), 
3.23 (dd, J = 3.1, 9.1 Hz, 1H), 3.08 (dd, J = 3.3, 14.0 Hz, 1H), 2.85–2.78 (m, 1H), 2.80 
(s, 3H); 13C NMR (100 MHz, CDCl3) ! 156.6, 144.9, 142.1, 133.8, 133.3, 130.5, 129.0, 
125.1, 117.7, 53.3, 48.2, 37.0, 34.4; IR (film) 1716 cm-1. MS (CI) 346.0956 (346.0953 
calcd for C17H16ClN3O3, M + H
+). The enantiopurity was determined to be 93% ee by 
chiral HPLC analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 




(2n). The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 2-bromonaphthalene (0.40 mmol, 82.8 mg) 
using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE (0.012 
mmol 6.1 mg), a reaction temperature of 115 °C and a reaction time of 18 h. This 
procedure afforded the title compound (51.3 mg, 71%) as a bright yellow solid, mp 152–
155 °C: ["]23D –116.7 (c 0.74, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ! 8.25 (d, J = 9.1 Hz, 
2H), 7.86–7.78 (m, 5H), 7.62 (s, 1H), 7.54–7.46 (m, 2H), 7.28 (d, J = 8.4 Hz, 1H), 4.68–
4.61 (m, 1H), 3.46 (app. t, J = 9.2 Hz, 1H), 3.36–3.28 (m, 2H), 2.93 (dd, J = 9.3, 13.9 
Hz, 1H), 2.81 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 156.7, 145.1, 142.0, 133.4, 133.0, 
132.4, 128.7, 128.0, 127.7, 127.4, 126.9, 126.5, 126.0, 125.0, 117.8, 53.6, 48.5, 37.9, 
30.8; IR (film) 1715 cm-1. MS (CI) 362.1507 (362.1499 calcd for C21H19N3O3, M + H
+). 
The enantiopurity was determined to be 89% ee by chiral HPLC analysis (chiralcel 






The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 4-(4-bromophenyl)morpholine (0.40 mmol, 
96.8 mg) using a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-
PE (0.012 mmol 6.1 mg), H2O (0.40 mmol, 7 $L) as an additive, a reaction temperature 
of 115 °C and a reaction time of 18 h. This procedure afforded the title compound (63.4 
mg, 80%) as a bright yellow solid, mp 125–129 °C: ["]23D –91.0 (c 0.97, CH2Cl2); 
1H 
NMR (400 MHz, CDCl3) ! 8.22 (d, J = 9.2 Hz, 2H), 7.78 (d, J = 9.2 Hz, 2H), 7.05 (d, J = 
8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 4.53–4.45 (m, 1H), 3.90–3.81 (m, 4H), 3.46 (app. 
t, J = 8.9 Hz, 1H), 3.27 (dd, J = 2.9, 9.2 Hz, 1H), 3.18–3.08 (m, 4H), 3.04 (dd, J = 3.2, 
14.1 Hz, 1H), 2.81 (s, 3H), 2.72 (dd, J = 8.8, 14.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
! 156.7, 150.4, 145.2, 141.9, 130.0, 126.6, 125.0, 117.7, 115.9, 67.1, 53.8, 49.3, 48.4, 
36.8, 30.8; IR (film) 1717 cm-1. MS (CI) 397.1872 (397.1870 calcd for C21H24N4O4 
M+H+). The enantiopurity was determined to be 87% ee by chiral HPLC analysis 
(chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 195 nm, RT= 25.7 




The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 4-bromoanisole (0.40 mmol, 74.8 mg) using 
a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE (0.012 
mmol 6.1 mg), TFA (0.08 mmol, 6 $L) as an additive, a reaction temperature of 115 °C 
and a reaction time of 18 h. This procedure afforded the title compound (55.3 mg, 81%) 
as a bright yellow solid, mp 110–113 °C: ["]23D –71.3 (c 0.98, CH2Cl2); 
1H NMR (400 
MHz, CDCl3) ! 8.22 (d, J = 9.2 Hz, 2H), 7.79 (d, J = 9.4 Hz, 2H), 7.06 (d, J = 8.5 Hz, 
2H), 6.85 (d, J = 8.5 Hz, 2H), 4.52–4.48 (m, 1H), 3.77 (s, 3H), 3.46 (app. t, J = 8.9 Hz, 
1H), 3.26 (dd, J = 3.2, 9.0 Hz, 1H), 3.04 (dd, J = 3.4, 14.1 Hz, 1H), 2.79 (s, 3H), 2.74 
(dd, J = 8.9, 14.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) ! 158.8, 156.7, 145.2, 141.9, 
130.2, 127.3, 125.0, 117.7, 114.3, 55.3, 53.7, 48.3, 36.8, 30.8; IR (film) 1717 cm-1. MS 
(CI) 342.1457 (342.1448 calcd for C18H19N3O4, M + H
+). The enantiopurity was 
determined to be 90% ee by chiral HPLC analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% 





The general procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-
nitrophenyl)urea (0.20 mmol, 47.0 mg) and 3-bromoanisole (0.40 mmol, 74.8 mg) using 
a catalyst composed of Pd2(dba)3 (0.004 mmol, 3.7 mg) and (S)-Siphos-PE (0.012 
mmol 6.1 mg), a reaction temperature of 115 °C and a reaction time of 18 h. This 
procedure afforded the title compound (51.2 mg, 75%) as a bright yellow solid, mp 110–
114 °C: ["]23D –94.2 (c 0.73, CH2Cl2);  
1H NMR (400 MHz, CDCl3) ! 8.20 (d, J = 9.1 Hz, 
2H), 7.77 (d, J = 9.3 Hz, 2H), 7.23 (t, J = 8.0 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 6.73 (d, J 
= 7.6 Hz, 1H), 6.65 (s, 1H), 4.56–4.48 (m, 1H), 3.76 (s, 1H), 3.44 (app. t, J = 9.0 Hz, 
1H), 3.26 (dd, J = 2.9, 9.2 Hz, 1H), 3.08 (dd, J = 3.3, 13.9 Hz, 1H), 2.79 (s, 3H), 2.73 
(dd, J = 9.0, 13.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) ! 159.9, 156.7, 145.1, 141.9, 
137.1, 129.9, 125.0, 121.4, 117.6, 115.4, 112.0, 55.2, 53.5, 48.4, 37.7, 30.8; IR (film) 
1716 cm-1. MS (CI) 342.1461 (342.1448 calcd for C18H19N3O4, M + H
+). The 
enantiopurity was determined to be 83% ee by chiral HPLC analysis (chiralcel ADH, 25 





(2r). The general procedure was employed for the coupling of 1-allyl-3-(4-cyanophenyl)-
1-methylurea (0.10 mmol, 21.5 mg) and 2-bromovinyltrimethylsilane (0.20 mmol, 35.8 
mg) using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-Siphos-PE 
(0.006 mmol, 3.0 mg), a reaction temperature of 120 °C and a reaction time of 14 h. 
This procedure afforded the title compound (20.0 mg, 64%) as a light orange solid, mp 
130–133 °C: ["]23D +6.4 (c 0.50, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ! 7.66 (d, J = 9.0 
Hz, 2H), 7.59 (d, J = 8.8 Hz, 2H), 5.87 (dt, J = 6.2, 18.5 Hz, 1H), 5.76 (d, J = 18.7 Hz, 
1H), 4.35 (m, 1H), 3.56 (app. t, J = 9.0 Hz, 1H), 3.23 (dd, J = 3.4, 9.1 Hz, 1H), 2.88 (s, 
3H) 2.53 (m, 1H), 2.38 (m, 1H) 0.04 (s, 9H); 13C NMR (100 MHz, CDCl3) ! 156.6, 143.1, 
138.8, 136.5, 133.0, 127.5, 119.1, 118.6, 105.0, 51.6, 48.8, 38.9, 30.8, –1.4; IR (film) 
1702 cm-1; MS (CI) 314.1685 (314.1683 calcd for C17H23N3OSi, M + H
+). The 
enantiopurity was determined to be 86% ee by chiral HPLC analysis (chiralcel ADH, 25 





yl}benzonitrile (2s). The general procedure was employed for the coupling of 1-allyl-3-
(4-cyanophenyl)-1-methylurea (0.10 mmol, 21.5 mg) and 4-bromobenzotrifluoride (0.20 
mmol, 45.0 mg), using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-
Siphos-PE (0.006 mmol, 3.0 mg), water (3.5 $L, 0.20 mmol) as an additive, a reaction 
temperature of 120 °C and a reaction time of 14 h. This procedure afforded the title 
compound (20.7 mg, 58%) as a light orange solid, mp 120–124 °C: ["]23D –29.5 (c 1.12, 
CH2Cl2); 
1H NMR (700 MHz, CDCl3) ! 7.72 (d, J= 8.9 Hz, 2H), 7.64 (d, J= 8.9 Hz, 2H), 
7.57 (d, J= 8.0 Hz, 2H), 7.27 (d, J= 8.2 Hz, 2H), 4.56-4.52 (m, 1H), 3.46 (app. t, J= 9.0 
Hz, 1H), 3.20 (dd, J= 3.4, 9.0 Hz, 1H), 3.13 (dd, J= 3.3, 14.1 Hz, 1H), 2.97 (dd, J= 8.7, 
14.0 Hz, 1H), 2.78 (s, 3H); 13C NMR (100 MHz, CDCl3) ! 156.7, 142.9, 139.7, 133.2, 
129.7 (q, 32.4 Hz), 129.6, 125.8(q, 3.8 Hz), 124.0 (q, 272.0 Hz), 119.1, 118.7, 105.5, 
53.0, 48.4, 37.5, 30.7 ; IR (film) 1717 cm-1; MS (CI) 360.1322 (360.1318 calcd for 
C19H16F3N3O, M + H
+). The enantiopurity was determined to be 77% ee by chiral HPLC 
analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 200nm, RT= 
8.9 and 16.6 min). 
(–)-5S-4-{3-Methyl-2-oxo-5-[4-(trifluoromethyl)benzyl]imidazolidin-1-
yl}benzonitrile. (2s): The general procedure was employed for the coupling of 1-allyl-3-
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(4-cyanophenyl)-1-methylurea (0.10 mmol, 21.5 mg) and 4-iodobenzotrifluoride (0.20 
mmol, 54.4 mg) using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-
Siphos-PE (0.006 mmol, 3.0 mg), water (3.5 $L, 0.20 mmol) as an additive, a reaction 
temperature of 120 °C and a reaction time of 14 h. This procedure afforded the title 
compound (27.9 mg, 77%) as a light orange oil. The enantiopurity was determined to be 





The general procedure was employed for the coupling of 1-allyl-3-(4-cyanophenyl)-1-
methylurea (0.10 mmol, 21.5 mg) and 4-bromotoluene (0.20 mmol, 34.2 mg) using a 
catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-Siphos-PE (0.006 mmol, 
3.0 mg), a reaction temperature of 120 °C and a reaction time of 14 h. This procedure 
afforded the title compound (26.3 mg, 86%) as a light orange solid, mp 123–126 °C: 
["]23D –55.7 (c 0.90, CH2Cl2); 
1H NMR (500 MHz, CDCl3) ! 7.77 (d, J = 9.0 Hz, 2H), 7.65 
(d, J = 9.0 Hz, 2H), 7.15 (d, J = 7.8 Hz, 2H), 7.05 (d, J = 8.0 Hz, 2H), 4.51–4.45 (m, 1H), 
3.44 (app. t, J = 9.0 Hz, 1H), 3.26 (dd, J = 3.7, 9.2 Hz, 1H), 3.09 (dd, J = 3.4, 13.9 Hz, 
1H), 2.82 (s, 3H) 2.72 (dd, J = 9.3, 13.9 Hz, 1H), 2.35 (s, 3H); 13C NMR (100 MHz, 
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CDCl3) ! 156.9, 143.2, 136.9, 133.1, 132.5, 129.5, 129.0, 119.2, 118.5, 105.0, 53.5, 
48.5, 37.2, 30.8, 21.0; IR (film) 1712 cm-1; MS (CI) 306.1608 (306.1601 calcd for 
C19H19N3O, M + H
+). The enantiopurity was determined to be 85% ee by chiral HPLC 
analysis (chiralcel ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 198 nm, 
RT= 5.4 and 8.6 min). 
(–)-(5S)-4-[3-Methyl-5-(4-methylbenzyl)-2-oxoimidazolidin-1-yl]benzonitrile (2t): 
The general procedure was employed for the coupling of 1-allyl-3-(4-cyanophenyl)-1-
methylurea (0.10 mmol, 21.5 mg) and 4-iodotoluene (0.20 mmol, 43.6 mg) using a 
catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-Siphos-PE (0.006 mmol, 
3.0 mg), a reaction temperature of 120 °C and a reaction time of 14 h. This procedure 
afforded the title compound (27.2 mg, 89%) as a light orange oil. The enantiopurity was 
determined to be 73% ee by chiral HPLC analysis. Spectroscopic data were identical to 




The general procedure was employed for the coupling of 1-allyl-3-(4-cyanophenyl)-1-
methylurea (0.10 mmol, 21.5 mg) and 4-bromoanisole (0.20 mmol, 37.4 mg) using a 
catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-Siphos-PE (0.006 mmol, 
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3.0 mg), a reaction temperature of 120 °C and a reaction time of 14 h. This procedure 
afforded the title compound in (23.5 mg, 73%) as a light orange solid, mp 87–91 °C: 
["]23D –52.9 (c 0.37, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ! 7.74 (d, J = 9.0 Hz, 2H), 7.63 
(d, J = 8.8 Hz, 2H), 7.06 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 4.46 (m, 1H), 3.79 
(s, 3H), 3.43 (app. t, J = 9.0 Hz, 1H), 3.24 (dd, J = 3.3, 9.2 Hz, 1H), 3.04 (dd, J = 3.3, 
14.0 Hz, 1H), 2.80 (s, 3H) 2.71 (dd, J = 9.0, 14.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) ! 
158.4, 156.9, 143.2, 133.1, 130.2, 127.5, 118.5, 114.2, 105.0, 55.3, 53.5, 48.5, 36.7, 
30.8; IR (film) 1711 cm-1; MS (CI) 322.1548 (322.1550 calcd for C19H19N3O2, M + H
+). 
The enantiopurity was determined to be 82% ee by chiral HPLC analysis (chiralcel 




(5): The general procedure was employed for the coupling of 1-methyl-1-(2-methylallyl)-
3-(4-nitrophenyl)urea (0.10 mmol, 24.9 mg) and 4-bromo-tert-butylbenzene (0.20 mmol, 
42.6 mg) using a catalyst composed of Pd2(dba)3 (0.002 mmol, 1.8 mg) and (S)-Siphos-
PE (0.006 mmol, 3.0mg), a reaction temperature of 135 °C and a reaction time of 18 h. 
This procedure afforded the title compound (27.5 mg, 72%) as a yellow oil: ["]23D +70.2 
(c 0.90, CH2Cl2); 
1H NMR (500 MHz, CDCl3) ! 8.24 (d, J = 9.1 Hz, 2H), 7.54 (d, J = 9.1 
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Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 7.03 (d, J = 8.1 Hz, 2H), 3.49 (d, J = 9.1 Hz, 1H), 3.11 
(d, J = 13.5 Hz, 1H), 3.23 (d, J = 8.8 Hz, 1H), 2.81 (d, J = 14.4 Hz, 1H), 2.74 (s, 3H), 
1.47, (s, 3H), 1.29 (s, 9H); 13C NMR (125 MHz, CDCl3) ! 158.0, 150.2, 144.5, 144.3, 
132.3, 129.7, 125.6, 125.4, 124.4, 61.5, 56.3, 44.2, 34.5, 313, 30.6, 25.1; IR (film) 1716 
cm-1; MS (CI) 382.2133 (382.2125 calcd for C22H27N3O3, M + H
+). The enantiopurity was 
determined to be 76% ee by chiral HPLC analysis (ADH, 25 cm x 4.6 mm, 15% 
IPA/Hexanes, 1.5 mL/min, # 198 nm, RT= 7.5 and 7.9 min.) 
 
Deuterium Labeling Studies: 
 
(Z)-1-(3-d-Allyl)-1-methyl-3-(4-nitrophenyl)urea ((Z)-d-1f):2 A flame dried round 
bottom flask equipped with a stir bar was cooled to rt under a stream of N2 and charged 
with N-methylallylamine ( 5.0 mmol, 0.47 mL) and Et2O (10 mL). The resulting solution 
was cooled to –42 °C using a CO2/CH3CN bath and stirred for 5 min. A solution of n-
BuLi in hexanes (3.12 mL, 1.6 M, 5 mmol) was added slowly and the resulting mixture 
was stirred at –42 °C for 20 min. A solution of t-BuLi in pentane (3.50 mL, 1.4 M, 5 
mmol) was added slowly and the resulting solution was stirred at –42 °C for 30 min. The 
CO2/CH3CN bath was replaced with a brine/ice bath and the reaction mixture was 
allowed to slowly warm to room temperature as the ice melted. The bath was removed 
and the mixture was stirred at rt for 1 h. The reaction mixture was then cooled to –78 °C 








resulting mixture was warmed to rt and stirred overnight. The reaction mixture was 
cooled to 0 °C, quenched with H2O (2 mL) and transferred to a separatory funnel. The 
mixture was extracted with Et2O (2 x 5 mL) and the combined organic layers were dried 
over anhydrous Na2SO4 and filtered to afford a solution of (Z)-N-methyl-3-
deuterioallylamine. The solution was transferred to a round bottom flask and cooled to 0 
°C. A solution of 4-nitrophenylisocyanate (3.63 mmol, 596 mg) in CH2Cl2 (4 mL) was 
slowly added and the resulting mixture was warmed to rt and stirred for 5 h. The 
reaction mixture was then concentrated in vacuo and the crude product was purified by 
flash chromatography on silica gel to afford the title compound as (315 mg, 37% yield, 
>95% deuterium incorporation) a yellow solid, mp 80–83 °C. 1H NMR (700 MHz, CDCl3) 
! 8.12 (d, J = 9.2 Hz, 2H), 7.51 (d, J = 9.2 Hz, 2H), 6.88 (s, br, 1H), 5.87–5.82 (m, 1H), 
5.27 (d, J = 10.4 Hz, 1H), 3.98 (d, J = 5.3 Hz, 2H), 3.03 (s, 3H); 13C NMR (175 MHz, 
CDCl3) ! 154.5, 145.5, 142.3, 132.7, 125.0, 118.4, 117.2 (t, J = 23.8 Hz), 51.6, 34.8; IR 





nitrophenyl)imidazolidin-2-one (d-2f). The general procedure was employed for the 
coupling of (Z)-1-(3-d-allyl)-1-methyl-3-(4-nitrophenyl)urea (0.10 mmol, 23.6 mg) and 4-
bromo-tert-butylbenzene (0.20 mmol, 42.6 mg) using a catalyst composed of Pd2(dba)3 









of 115 °C, and a reaction time of 18 h. This procedure afforded the title compound (32.1 
mg, 85%) as a bright yellow solid, mp 110–113 °C, ["]23D –104 (c 1.00, CH2Cl2). This 
material was judged to be a 7:1 mixture of diastereomers by 1H NMR analysis. Data are 
for the major isomer:  1H NMR (700 MHz, CDCl3) ! 8.22 (d, J = 8.9 Hz, 2H), 7.78 (d, J = 
8.9 Hz, 2H), 7.34 (d, J = 7.8 Hz, 2H), 7.09 (d, J = 8.2 Hz, 2H), 4.54–4.50 (m, 1H), 3.48 
(app. t, J = 8.7 Hz, 1H), 3.29 (dd, J = 2.6, 9.0 Hz, 1H), 3.09 (d, J = 3.2 Hz, 0.12 H), 2.74 
(d, J = 9.0 Hz, 0.88 H), 2.83 (s, 3H), 1.30 (s, 9H); 13C NMR (175 MHz, CDCl3) ! 156.7, 
150.3, 145.2, 141.9, 132.4, 128.8, 125.8, 125.0, 117.7, 53.7, 48.6, 37.0 (t, J = 17.7 Hz), 
34.5, 31.3, 30.8; IR (film) 1717 cm-1. MS (CI) 369.2034 (369.2031 calcd for 
C21H24DN3O3, M + H
+). The enantiopurity was determined to be 91% ee by chiral HPLC 
analysis (ADH, 25 cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 198 nm, RT= 6.3 and 
9.5 min). The 1’R,4S relative stereochemistry was assigned on the basis of comparison 
of NMR data to those obtained for a sample of the title compound prepared using a 
catalyst composed of Pd2(dba)3 and DPE-Phos, which has previously been shown to 
effect the syn-carboamination of N-allylurea derivatives.1 
 
Discussion of Mechanism of Diastereomer Formation in the Reaction of (Z)-d-1f 
The formation of the minor diastereomer in the reaction of (Z)-d-1f is likely due to 
competing !-hydride elimination processes, as we have previously observed in related 
tetrahydrofuran-forming reactions.[4] As shown below in Scheme S1, intermediate S1 
(generated via oxidative addition of the aryl bromide to Pd(0) followed by deprotonation 
and transmetallation of the substrate) is formed from (Z)-d-1f. The syn-migratory 
insertion of the alkene into the Pd–N bond affords S2, which can undergo reductive 
!!!!!!!!!!!!!!!!!!! ! !!!!!!!!!!"!%%!
elimination to yield (1’R,4S)-d-2m. However, if this reductive elimination is relatively 
slow, S2 can undergo sigma bond rotation to S2a followed by syn-!-hydride elimination 
to afford S3. Reinsertion of the alkene into the Pd–H bond with the opposite 
regiochemistry provides S4, which can undergo sigma bond rotation to S4a. The syn-!-
hydride elimination of H from S4a provides S5, which can undergo reinsertion of the 
alkene into the Pd–H bond to give S6. Reductive elimination from S6 then affords the 
minor diastereomer (1’S,4S)-d-2m. No migration of the deuterium atom was observed, 
which is presumably a result of a kinetic isotope effect coupled with the statistical 
probability for !-H vs. !-D elimination. 
























































































































Deprotection of 2m and Assignment of Absolute Stereochemistry: 
The absolute stereochemistry of the urea products was assigned by deprotection of 2m 
(prepared via Pd-catalyzed carboamination of 1f) to urea 6. The optical rotation of 6 was 




(–)-(4S)-4-Benzyl-1-methyl-3-(4-nitrophenyl)imidazolidin-2-one (2m): The general 
procedure was employed for the coupling of 1-allyl-1-methyl-3-(4-nitrophenyl)urea (1.0 
mmol, 235.2 mg) and bromobenzene (1.2 mmol, 188.4 mg) using a catalyst composed 
of Pd2(dba)3 (0.02 mmol, 18.0 mg) and (S)-Siphos-PE (0.06 mmol, 30.0 mg), a reaction 
temperature of 115 °C, and a reaction time of 18 h. This procedure afforded the title 
compound (256.9 mg, 83%) as a bright yellow solid, mp 125–128 °C: ["]23D –108.9 (c 
1.22, CH2Cl2); 
1H NMR (500 MHz, CDCl3) ! 8.24 (d, J = 9.3 Hz, 2H), 7.80 (d, J = 9.3 Hz, 
2H), 7.33 (t, J = 6.9 Hz, 2H), 7.28 (t, J = 7.3 Hz, 1H), 7.06 (d, J = 7.1 Hz, 2H), 4.58–4.52 
(m, 1H), 3.47 (app. t, J = 8.8 Hz, 1H), 3.28 (dd, J = 2.9, 9.2 Hz, 1H), 3.14 (dd, J = 3.2, 
13.9 Hz, 1H), 2.83–2.77 (m, 1H), 2.81 (s, 3H); 13C NMR (125 MHz, CDCl3) ! 156.7, 
145.1, 142.0, 135.5, 129.2, 128.9, 127.3, 125.0, 117.7, 53.7, 48.4, 37.7, 30.8; IR (film) 
1717 cm-1; MS (CI) 312.1347 (312.1343 calcd for C17H17N3O3, M + H
+). The 
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enantiopurity was determined to be 89% ee by chiral HPLC analysis (chiralcel ADH, 25 
cm x 4.6 mm, 15% IPA/Hexanes, 1.5 mL/min, # 198 nm, RT= 10.5 and 17.1 min). 
 
!
(–)-(4S)-4-Benzyl-1-methylimidazolidin-2-one (6). A glass microwave tube equipped 
with a stirbar was charged with 4-Benzyl-1-methyl-3-(4-nitrophenyl)imidazolidin-2-one 
(77.8 mg, 0.25 mmol,), 10% Pd/C (38.9 mg, 5% w/w Pd), ethyl acetate (2 mL) and 
methanol (1 mL). The tube was placed into a stainless steel bomb that was pressurized 
with H2 to 50 psi and the reaction mixture was then stirred at rt for 12 h. The reaction 
vessel was then depressurized and the mixture was filtered through a pad of celite. The 
celite was washed with methanol (25 mL) and the combined organic solutions were 
concentrated in vacuo. The crude product from this reaction was dissolved in CH2Cl2 
(0.7 mL) and transferred to a flame dried Schlenk tube equipped with a stir bar that had 
been cooled under a stream of nitrogen. Acetic anhydride (28 $L, 0.30 mmol) was 
added to the flask and the resulting solution was stirred at rt for 5 h. A solution of 
saturated aqueous Na2CO3 (5 mL) was added to the reaction vessel and  the resulting 
mixture was transferred to a separatory funnel. The mixture was extracted with CH2Cl2 
(3 x 10 mL) and the combined organic layers were dried over anhydrous sodium sulfate, 
filtered, and concentrated in vacuo. The crude product from this reaction was placed 
into a round bottom flask equipped with a stir bar and dissolved in CH3CN (3.5 mL) and 
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H2O (0.70 mL). The mixture was cooled to 0 °C, stirred for 5 min, then ceric ammonium 
nitrate (1.13 mmol, 618.0 mg) was added in one portion. The resulting mixture was 
stirred at 0 °C for 25 min then saturated aqueous sodium sulfite (6 mL) was added. The 
mixture was transferred to a separatory funnel and extracted with ethyl acetate (3 x 10 
mL). The combined organic layers were washed with saturated aqueous NaHCO3 (5 
mL) and brine (5 mL) then dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography on 
silica gel to afford the title compound (41.6 mg, 88% overall yield) as a brown oil, ["]23D 
–27.0 (c 1.0, CH2Cl2); 
1H NMR (500 MHz, CDCl3) ! 7.30 (t, J = 7.1 Hz, 2H), 7.24 (t, J = 
7.6 Hz, 1H), 7.17 (d, J = 7.1 Hz, 2H), 4.82–4.52 (s, br, 1H), 3.85 (m, 1H), 3.47 (app. t, J 
= 8.6 Hz, 1H), 3.13 (dd, J = 6.1, 8.8 Hz, 1H), 2.81 (app. d, J = 7.1 Hz, 2H), 2.76 (s, 3H); 
13C NMR (125 MHz, CDCl3) ! 161.9, 137.1, 129.0, 128.8, 126.9, 52.7, 51.1, 42.0, 30.5; 
IR (film) 1699 cm-1; MS (CI) 191.1181 (191.1179 calcd for C11H14N2O, M + H
+). The 
enantiopurity was determined to be 85% ee by chiral HPLC analysis (Lux Amylose-2, 25 
cm x 4.6 mm, 10% IPA/Hexanes, 1.0 mL/min, # 210 nm, RT= 21.3 and 22.7 min). 
 
!
(–)-(4S)-4-Benzyl-1-methylimidazolidin-2-one (6) A flame-dried round bottomed flask 
equipped with a stirbar was cooled under a stream of nitrogen and charged with (S)-N1-
methyl-3-phenylpropane-1,2-diamine3 (100.0 mg, 0.60 mmol) and THF (1 mL). Solid 
CDI (90.0 mg, 0.56 mmol) was added and the resulting mixture was heated to 60 °C 
with stirring for 12 h. The reaction mixture was then cooled to rt and the solvent was 
!!!!!!!!!!!!!!!!!!! ! !!!!!!!!!!"!%)!
removed in vacuo. The product was purified by flash chromatography on silica gel to 
afford the title compound (32.0 mg, 30% yield); ["]23D –37.2 (c 0.90, CH2Cl2). The 
spectroscopic properties of this compound were identical to that of compound 6. The 
enantiopurity was determined to be 97% ee by chiral HPLC analysis (Lux Amylose-2, 25 
cm x 4.6 mm, 10% IPA/Hexanes, 1.0 mL/min, # 210 nm, RT= 21.3 and 22.7 min). 
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